InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Hwang Kuk Hyoun. Officer active across 2 companies, notably Bellevue Life Sciences Acquisition Corp.. Cumulatively, 4 reports have been published. Activity tracked since 14 February 2023. The latest transaction was disclosed on 14 February 2025 (J). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Hwang Kuk Hyoun is a declarant with 4 filings in total. The 4 sampled filings run from 2023-02-16 to 2025-02-19 and concern Bellevue Life Sciences Acquisition Corp. and OSR Holdings, Inc., where he is Chief Executive Officer and President and CEO. The buy and sell amounts shown for these sampled filings are 0 and 0.